These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 3442730

  • 1. Combination of 5-fluorouracil and cyclophosphamide in L1210 and P388 leukemias with changes in optimum treatments as a function of the age of the L1210 tumor at first treatment.
    Wampler GL, Carter WH, Campbell ED.
    Cancer Invest; 1987; 5(6):523-33. PubMed ID: 3442730
    [Abstract] [Full Text] [Related]

  • 2. Synergistic action of 2-chlorodeoxyadenosine and cyclophosphamide on murine leukemias L1210 and P388.
    Góra-Tybor J, Robak T.
    Acta Haematol Pol; 1993; 24(2):177-82. PubMed ID: 8103959
    [Abstract] [Full Text] [Related]

  • 3. Influence of molar ratio on the combination effect of 5-fluorouracil with guanosine 5'-monophosphate on P388 and L1210 leukemias.
    Iigo M, Hoshi A.
    Eur J Cancer Clin Oncol; 1984 Mar; 20(3):411-5. PubMed ID: 6323189
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Schedule-dependent variations in the response of murine P388 leukemia to cyclophosphamide in combination with interferons-alpha/beta.
    Borden EC, Sidky YA, Hatcher JF, Bryan GT.
    Cancer Res; 1988 May 01; 48(9):2329-34. PubMed ID: 3356000
    [Abstract] [Full Text] [Related]

  • 7. Additive action of gemcitabine (2',2'-difluorodeoxycytidine) and 2-chlorodeoxyadenosine on murine leukemias L1210 and P388.
    Marañda E, Szmigielska A, Robak T.
    Cancer Invest; 1999 May 01; 17(2):95-101. PubMed ID: 10071592
    [Abstract] [Full Text] [Related]

  • 8. Cross-resistance of drug-resistant murine leukemias to deoxyspergualin (NSC 356894) in vivo.
    Harrison SD, Brockman RW, Trader MW, Laster WR, Griswold DP.
    Invest New Drugs; 1987 Dec 01; 5(4):345-51. PubMed ID: 3436739
    [Abstract] [Full Text] [Related]

  • 9. Mitomycin C combination therapy against murine tumor systems. Effectiveness with cyclophosphamide and methotrexate.
    Mabel JA, Wodinsky I.
    Cancer; 1983 Feb 15; 51(4):600-5. PubMed ID: 6401590
    [Abstract] [Full Text] [Related]

  • 10. An improved method for analyzing survival data from combination chemotherapy experiments.
    Carter WH, Stablein DM, Wampler GL.
    Cancer Res; 1979 Sep 15; 39(9):3446-53. PubMed ID: 476674
    [Abstract] [Full Text] [Related]

  • 11. Effects of cimetidine combination with cyclophosphamide in transplanted murine tumors.
    Khandalekar DD, Ganu UK, Gokhale SV.
    Indian J Physiol Pharmacol; 1989 Sep 15; 33(3):171-4. PubMed ID: 2592043
    [Abstract] [Full Text] [Related]

  • 12. Potentiation of the activity of cisplatin and cyclophosphamide by trimidox, a novel ribonucleotide reductase inhibitor, in leukemia-bearing mice.
    Novotny L, Rauko P, Liska J, Elford HL, Szekeres T.
    Cancer Lett; 2006 Feb 20; 233(1):178-84. PubMed ID: 15885888
    [Abstract] [Full Text] [Related]

  • 13. Comparison of 5-fluorouracil and ftorafur. II. Therapeutic response and development of resistance in murine tumors.
    Garibjanian BT, Johnson RK, Kline I, Vadlamudi S, Gang M, Venditti JM, Goldin A.
    Cancer Treat Rep; 1976 Sep 20; 60(9):1347-61. PubMed ID: 797450
    [Abstract] [Full Text] [Related]

  • 14. Combination chemotherapy with a new folate analog: activity of 10-ethyl-10-deaza-aminopterin compared to methotrexate with 5-fluorouracil and alkylating agents against advanced metastatic disease in murine tumor models.
    Schmid FA, Sirotnak FM, Otter GM, DeGraw JI.
    Cancer Treat Rep; 1987 Sep 20; 71(7-8):727-32. PubMed ID: 3607784
    [Abstract] [Full Text] [Related]

  • 15. Effect of 3'-amino-3'-deoxythymidine on L1210 and P388 leukemias in mice.
    Lin TS, Fischer PH, Prusoff WH.
    Biochem Pharmacol; 1982 Jan 01; 31(1):125-8. PubMed ID: 7059345
    [No Abstract] [Full Text] [Related]

  • 16. Dexamethasone does not enhance antileukemic activity of cladribine in mice with leukemias L1210 and P388.
    Robak T, Szmigielska A.
    Neoplasma; 2000 Jan 01; 47(3):168-71. PubMed ID: 11043840
    [Abstract] [Full Text] [Related]

  • 17. Timing- and sequence-dependent synergism between etoposide and methotrexate or etoposide, methotrexate and 5-fluorouracil in advanced leukemia L1210.
    Osswald H, Herrmann R, Youssef M.
    Cancer Lett; 1985 Dec 01; 29(3):277-82. PubMed ID: 4075296
    [Abstract] [Full Text] [Related]

  • 18. L-histidinol: preclinical therapeutic studies in combination with antitumor agents and pharmacokinetic studies in mice.
    Zaharko D, Plowman J, Waud W, Dykes D, Malspeis L.
    Cancer Res; 1992 Jul 01; 52(13):3604-9. PubMed ID: 1617631
    [Abstract] [Full Text] [Related]

  • 19. Overadditive synergism between the intercalators mitoxantrone and lucanthone in advanced L 12010 and P 388 leukemia.
    Osswald H, Youssef M.
    J Cancer Res Clin Oncol; 1986 Jul 01; 111(2):137-40. PubMed ID: 2939092
    [Abstract] [Full Text] [Related]

  • 20. [Effect of biological response modifier sulfoethylated (1 --> 3)-beta-D-glycan on the experimental leukemia in mice].
    Khalikova TA, Korolenko TA.
    Eksp Klin Farmakol; 2006 Jul 01; 69(5):39-43. PubMed ID: 17153965
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.